Grant Funding

Grant Funding - Press Release - March 2018

Cure Glaucoma Foundation (CGF) is pleased to have completed our glaucoma research grant funding cycle.

The CGF Research Committee received exceptional proposals from a number of highly qualified researchers. Dr. Davinder Grover chaired the discussions when committee members met to examine the technical merits of the research proposals along with their alignment with CGF’s research mission.

The recommendations proposed by the research committee were unanimously supported by the CGF Board and we are pleased to announce that the following two $25,000 research grants were awarded:

Dr. Porciatti:

Anesthetic Preconditioning as Endogenous Neuroprotection in Glaucoma; Bascom Palmer

The purpose of this study is to test whether the nerve cells damaged by glaucoma can be protected by the use of a common ophthalmologic anesthetic. Although this study involves mice, the long term results could yield additional treatments for glaucoma that are not purely based on lowering eye pressure.

Dr. Tseng:

Neurodegenerative Biomarkers in Primary Open Angle Glaucoma; Duke Eye Center

The principle investigator’s previous studies have shown that as nerve cells die they emit high levels of specific proteins. The purpose of this study is to determine if specific protein levels can be used to provide early detection of open angle glaucoma (independent of eye pressure) and to monitor the progression of the disease.

On behalf of the CGF Board, please accept our congratulations for the award and best wishes for the coming year.

Sincerely,

Dr. Tosin Smith

Executive Director – Cure Glaucoma Foundation

Support Cure Glaucoma Foundation with a donation

or mail to:

10740 N. Central Expwy.

Suite 300

Dallas, TX 75231